Axios Pro Rata

Axios Pro Rata Editions

41 editions with AI-generated summaries

Axios Pro Rata: Minnesota mail

In this edition of Axios Pro Rata, key highlights include heartfelt anecdotes from readers in the Twin Cities about the impact of recent ICE activities, emphasizing community and family fears. On the business front, Anta Sports has acquired a 29% stake in Puma for €1.51 billion, seeking to strengthen its position against Nike, while various venture capital deals signal significant funding activity across sectors like healthcare and AI. For those interested in investing or following market trends, keep an eye on these developments!

👑 Axios Pro Rata: California's crown

In today’s Axios Pro Rata, key highlights include California continuing to dominate U.S. venture capital, securing 62% of funds raised in 2025, despite critiques of its tax environment. Additionally, the U.S. government has entered a $1.6 billion partnership with USA Rare Earths to enhance domestic supply of critical materials. Actionable insights include a request for feedback from Twin Cities residents on recent events and the potential IPOs to watch this week, including Bob's Discount Furniture and Helix Acquisition III.

Axios Pro Rata: TikTok'd

In today's Axios Pro Rata, we see major developments as ByteDance officially divests TikTok U.S. to investors including Silver Lake and Oracle, sparking anticipation for a future IPO. Additionally, Capital One acquires Brex for $5.15 billion, marking significant shifts in the fintech landscape. For investors, keep an eye on emerging AI opportunities and recent funding rounds, as venture capital continues to flow into innovative sectors.

Axios Pro Rata: VC vs. Korea

In today’s Axios Pro Rata, we spotlight the lawsuit by Silicon Valley firms Greenoaks and Altimeter against South Korea, alleging anti-competitive actions against Coupang; this could strain U.S.-Korea relations. Additionally, EQT is set to acquire Coller Capital for $3.7 billion, highlighting the growing demand in the secondaries market. Don't miss the latest funding rounds, including OpenAI's potential $50 billion raise!

🌭 Axios Pro Rata: Hot dog deal

In today’s Axios Pro Rata, BlackRock's potential $22.8 billion acquisition of Panama ports faces uncertainty as the Supreme Court evaluates CK Hutchison's concession contracts. Meanwhile, Smithfield Foods has made headlines by acquiring the hot dog brand Nathan's Famous for $450 million, marking a significant move in the food sector. For venture capitalists, notable fundraising includes Baseten raising $300 million and OpenEvidence securing $250 million, reflecting ongoing investment interest in AI and healthcare.

Axios Pro Rata: Netflix and cash

In today’s newsletter, Netflix ups its takeover bid for Warner Bros. Discovery to an all-cash offer of $83 billion, signaling increased competition in the media space. Additionally, the IPO filing for SOLV Energy highlights the growing significance of data centers in the renewable energy sector, indicating a potential surge in solar investments. For those attending Davos, be sure to check out Axios House for insightful discussions!

Axios Pro Rata: Trump ROI

In the latest Axios Pro Rata, key highlights include President Trump's continued strategy of U.S. government investments in private companies, resulting in significant short-term stock price increases for involved firms. Additionally, Devon Energy and Coterra Energy are in early talks for a major shale merger, potentially reshaping the independent shale sector. Mark your calendars for next week's Axios House at Davos, featuring influential industry leaders and engaging discussions.

Axios Pro Rata: Bain's new boss

In today’s Axios Pro Rata, David Gross has stepped into the role of managing partner at Bain Capital, eyeing the integration of AI into investment processes while projecting a positive outlook for deal activity in 2026. Notably, Mission Produce is acquiring Calavo Growers for $483 million, creating a dominant player in the avocado market. For venture capital enthusiasts, significant fundraising highlighted includes SkildAI's $1.4 billion round and Parloa's $350 million Series D.

Thought bubble: JPM's AI buzz

At the recent JPMorgan Healthcare Conference, the conversation around biotech is buzzing with AI potential, although no fully AI-developed drugs are on the market yet. Expect FDA approval for the first AI-enabled drug in two to three years, with companies focusing on bolstering in-house AI capabilities. Additionally, the hype around AI is attracting more investment into biotech, signaling exciting times ahead.

Axios Pro Rata: Luxury loser

In today's Axios Pro Rata, key highlights include hedge fund billionaire Steve Cohen pulling back on fintech investments and placing a significant portion of his portfolio into a continuation vehicle. Additionally, Saks Global has filed for Chapter 11 bankruptcy, prompting potential acquisition interest. Investors should note the shift in alt asset sentiment, which shows declining stocks, except for Carlyle, amidst competing growth reports from major banks. Keep an eye on upcoming IPOs like BitGo, and check out the latest funding rounds in various tech sectors.

Axios Pro Rata: Export exam

In today's Axios Pro Rata, Dan Primack reflects on nine years of the newsletter with gratitude towards readers. Key highlights include China's review of Meta's acquisition of Manus AI, which might affect the future of "Singapore-washing" and create complications for Chinese tech investments. Also noteworthy is the significant $2.5 billion valuation of WebAI, which aims to enhance AI privacy by running processes directly on devices. For investors, several new funding rounds are announced, and the monthly inflation rate remains steady at 0.3%.

Axios Pro Rata: Bio boom

In today's newsletter, Dan Primack highlights the booming biotech sector in early 2026, with significant venture capital deals and IPOs making headlines. Notably, Dina Powell McCormick is joining Meta, signaling a shift in leadership dynamics, while Allegiant's $1.5 billion acquisition of Sun Country Airlines is poised to test antitrust waters under the new administration. If you’re attending the JPMorgan Healthcare Conference, check out Axios Live tonight for insights from industry leaders!

Like what you see?

Subscribe to Axios Pro Rata and get fresh content delivered to your inbox.